Can B Stock Price, News & Analysis
Company Description
Can B (OTC Link: CANB) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $1.4M.
CANB stock has gained 80.0% over the past year. Shares last traded at $0.0180.
On a trailing twelve-month basis, Can B reported revenue of $2.2M with net income of -$9.7M and diluted earnings per share of $-0.77. The company operates at a net profit margin of -451.7%.
This page provides a comprehensive overview of CANB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Can B (CANB) stock last traded at $0.0180. Over the past 12 months, the stock has gained 80.0%. At a market capitalization of $1.4M, CANB is classified as a micro-cap stock with approximately 78.0M shares outstanding.
Latest News
Can B has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences. View all CANB news →
SEC Filings
Financial Highlights
Can B generated $2.2M in revenue over the trailing twelve months, retaining a 16.6% gross margin, operating income reached -$7.5M (-347.3% operating margin), and net income was -$9.7M, reflecting a -451.7% net profit margin. Diluted earnings per share stood at $-0.77. The company generated -$1.3M in operating cash flow. With a current ratio of 0.45, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Can B (CANB) currently stands at 69.9 thousand shares, up 100.0% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 632.9%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Can B (CANB) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CANB Company Profile & Sector Positioning
Can B (CANB) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CANB often look at related companies in the same sector, including Cbd Denver Inc (CBDD), Ovation (OVATF), Software Effective Solutions (SFWJ), City View Green Hldgs Inc (CVGRF), and WEST IS BRANDS INC (WIBFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CANB's relative position within its industry.